Published in Psychopharmacology (Berl) on June 01, 1998
Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data. Psychopharmacology (Berl) (2003) 1.66
Relative reinforcing effects of three opioids with different durations of action. J Pharmacol Exp Ther (2002) 1.63
Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry (2008) 1.54
Sensitization of the reinforcing effects of self-administered cocaine in rats: effects of dose and intravenous injection speed. Eur J Neurosci (2005) 1.29
Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav (2006) 1.28
Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav (2008) 1.17
Effect of rate of delivery of intravenous cocaine on self-administration in rats. Pharmacol Biochem Behav (2009) 1.01
Brain temperature change and movement activation induced by intravenous cocaine delivered at various injection speeds in rats. Psychopharmacology (Berl) (2005) 1.01
Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys. Neuropsychopharmacology (2010) 1.00
A stimulus-control account of regulated drug intake in rats. Psychopharmacology (Berl) (2007) 0.92
Rats markedly escalate their intake and show a persistent susceptibility to reinstatement only when cocaine is injected rapidly. J Neurosci (2010) 0.92
Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys. Exp Clin Psychopharmacol (2011) 0.92
The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats. Pharmacol Biochem Behav (2008) 0.92
Stimulus control of cocaine self-administration. J Exp Anal Behav (2003) 0.91
Self-administration of (+)-methamphetamine and (+)-pseudoephedrine, alone and combined, by rhesus monkeys. Pharmacol Biochem Behav (2010) 0.87
Animal models of cannabinoid reward. Br J Pharmacol (2010) 0.84
Neuroimaging and drug taking in primates. Psychopharmacology (Berl) (2011) 0.83
Rate-dependent effects of monoamine releasers on intracranial self-stimulation in rats: implications for abuse liability assessment. Behav Pharmacol (2013) 0.83
Rapid delivery of cocaine facilitates acquisition of self-administration in rats: an effect masked by paired stimuli. Pharmacol Biochem Behav (2011) 0.82
Acquisition of cocaine self-administration with unsignaled delayed reinforcement in rhesus monkeys. J Exp Anal Behav (2005) 0.79
Intravenous saline injection as an interoceptive signal in rats. Psychopharmacology (Berl) (2011) 0.79
Cues paired with either rapid or slower self-administered cocaine injections acquire similar conditioned rewarding properties. PLoS One (2011) 0.78
The speed of cocaine delivery determines the subsequent motivation to self-administer the drug. Neuropsychopharmacology (2013) 0.78
Shallow discounting of delayed cocaine by male rhesus monkeys when immediate food is the choice alternative. Exp Clin Psychopharmacol (2016) 0.77
EVALUATION OF DRUG ABUSE TREATMENT MEDICATIONS: CONCORDANCE BETWEEN CLINICAL AND PRECLINICAL STUDIES. NIDA Res Monogr (2005) 0.76
Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation. Psychopharmacology (Berl) (2016) 0.75
Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (1987) 6.58
Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene (2002) 4.15
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A (2005) 2.96
Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry (1996) 2.95
Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90
Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol (1993) 2.31
Differentiating new marijuana use from residual drug excretion in occasional marijuana users. J Anal Toxicol (1998) 1.99
Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science (1981) 1.91
Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci (2000) 1.85
A transposon-like element in human DNA. Nature (1985) 1.81
Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction (1997) 1.79
Lobeline inhibits the neurochemical and behavioral effects of amphetamine. J Pharmacol Exp Ther (2001) 1.77
The endocannabinoid system in brain reward processes. Br J Pharmacol (2008) 1.71
Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther (1973) 1.68
Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci (1990) 1.68
Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH) J Anal Toxicol (1993) 1.66
Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. J Pharmacol Exp Ther (1971) 1.64
Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry (1990) 1.54
Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition. Psychopharmacology (Berl) (1997) 1.54
Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein. EMBO J (1996) 1.51
The metabolism and excretion of buprenorphine in humans. Drug Metab Dispos (1985) 1.49
Effects of cocaine and d-amphetamine on behavior maintained under various schedules of food presentation in squirrel monkeys. J Pharmacol Exp Ther (1977) 1.49
Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol (1996) 1.47
Buprenorphine treatment of pregnant opioid--dependent women: maternal and neonatal outcomes. Drug Alcohol Depend (2001) 1.46
Cocaine use early in treatment predicts outcome in a behavioral treatment program. J Consult Clin Psychol (1998) 1.46
Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol (2001) 1.41
Nicotine as a reinforcer in human subjects and laboratory animals. Pharmacol Biochem Behav (1983) 1.40
The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther (1991) 1.39
Cocaine self-administration increased by compounding discriminative stimuli. Psychopharmacology (Berl) (1996) 1.38
The kinetics of haematopoiesis in the calf. I. An autoradiographical study of myelopoiesis in normal, anaemic and endotoxin treated calves. Res Vet Sci (1971) 1.33
Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol (1999) 1.32
Detection times of marijuana metabolites in urine by immunoassay and GC-MS. J Anal Toxicol (1995) 1.29
Drug self-administration by laboratory animals: control by schedules of reinforcement. Annu Rev Pharmacol Toxicol (1978) 1.27
A comparison of pentobarbital and cocaine self-administration in rhesus monkeys: effects of dose and fixed-ratio parameter. J Pharmacol Exp Ther (1971) 1.23
A comparison of nicotine and cocaine self-administration in the dog: fixed-ratio and progressive-ratio schedules of intravenous drug infusion. J Pharmacol Exp Ther (1983) 1.22
Subjective and physiologic effects of intravenous buprenorphine in humans. Clin Pharmacol Ther (1993) 1.19
Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther (1996) 1.16
Maintenance of schedule-controlled behavior by intravenous injections of nicotine in squirrel monkeys. J Pharmacol Exp Ther (1982) 1.14
Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology (Berl) (2000) 1.12
The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend (2000) 1.12
Adenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry implications for drug addiction, sleep and pain. Prog Neurobiol (2007) 1.10
Some effects of cocaine and two cocaine analogs on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther (1977) 1.08
Selective trapping of circular double-stranded DNA molecules in solidifying agarose. Plasmid (1982) 1.08
Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats. Psychopharmacology (Berl) (2000) 1.08
Stimuli associated with drug injections as events that control behavior. Pharmacol Rev (1975) 1.08
Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers. J Anal Toxicol (2000) 1.07
Characterization of the absorption phase of marijuana smoking. Clin Pharmacol Ther (1992) 1.07
Chronic caffeine exposure potentiates nicotine self-administration in rats. Psychopharmacology (Berl) (1999) 1.07
Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology (Berl) (1999) 1.07
Disposition of heroin and its metabolites in heroin-related deaths. J Anal Toxicol (1994) 1.07
The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol (1998) 1.05
Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing. J Anal Toxicol (1999) 1.05
Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys. Fed Proc (1982) 1.04
Morphine: conditioned increases in self-administration in rhesus monkeys. Science (1969) 1.04
Selective associations produced solely with appetitive contingencies: the stimulus-reinforcer interaction revisited. J Exp Anal Behav (1993) 1.04
Cocaine self-administration appears to be mediated by dopamine uptake inhibition. Prog Neuropsychopharmacol Biol Psychiatry (1988) 1.04
Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Brain Res Mol Brain Res (1993) 1.03
Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav (1967) 1.02
HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives for evidence of viral exposure? N Engl J Med (1986) 1.02
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression. Brain Res Mol Brain Res (1999) 1.02
Suppression of behavior by intravenous injections of nicotine or by electric shocks in squirrel monkeys: effects of chlordiazepoxide and mecamylamine. J Pharmacol Exp Ther (1983) 1.01
Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol Biochem Behav (1990) 1.01
The reproductive cycle of the western whiptail lizard (Cnemidophorus tigris) in Southern Arizona. J Morphol (1966) 1.01
Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol (1995) 1.01
Genetic approaches to the analysis of addiction processes. Trends Pharmacol Sci (1989) 1.01
Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction (1998) 1.01
Testicular myxosporidiasis in the flat-backed toad, Bufo maculatus (Amphibia: Bufonidae), from Cameroon, Africa. J Wildl Dis (1992) 1.01
Effects of compounding drug-related stimuli: escalation of heroin self-administration. J Exp Anal Behav (2000) 1.01
Control of behavior by intravenous nicotine injections in laboratory animals. Pharmacol Biochem Behav (1983) 1.00
Single-incentive selective associations produced solely as a function of compound-stimulus conditioning context. J Exp Psychol Anim Behav Process (1993) 1.00
Effects of dopamine and serotonin-releasing agents on methamphetamine discrimination and self-administration in rats. Psychopharmacology (Berl) (1999) 1.00
Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther (1991) 1.00
Urinary excretion half-life of 11-nor-9-carboxy-delta9-tetrahydrocannabinol in humans. Ther Drug Monit (1998) 0.99
The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res (1993) 0.99
Fixed-interval responding under second-order schedules of food presentation or cocaine injection. J Exp Anal Behav (1977) 0.99
Histamine as a punisher in squirrel monkeys: effects of pentobarbital, chlordiazepoxide and H1- and H2-receptor antagonists on behavior and cardiovascular responses. J Pharmacol Exp Ther (1980) 0.98
The effects of chronic buprenorphine treatment on cocaine and food self-administration by rhesus monkeys. J Pharmacol Exp Ther (1992) 0.98
Butyrylcholinesterase accelerates cocaine metabolism: in vitro and in vivo effects in nonhuman primates and humans. Drug Metab Dispos (2000) 0.97
Anaphylactic shock following indocyanine green angiography. Arch Ophthalmol (1996) 0.97
Control of behavior by intravenous nicotine injections in human subjects. Pharmacol Biochem Behav (1983) 0.97
Structure of extrachromosomal circular DNAs containing both the Alu family of dispersed repetitive sequences and other regions of chromosomal DNA. J Mol Biol (1984) 0.97
Alteration of the behavioral effects of nicotine by chronic caffeine exposure. Pharmacol Biochem Behav (2000) 0.97
Conditioned locomotor-activating and reinforcing effects of discrete stimuli paired with intraperitoneal cocaine. Behav Pharmacol (1997) 0.96
Behavior maintained under a second-order schedule by intramuscular injection of morphine or cocaine in rhesus monkeys. J Pharmacol Exp Ther (1976) 0.95
Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J Pharmacol Exp Ther (1997) 0.95
Behavior maintained under second-order schedules of intravenous morphine injection in squirrel and rhesus monkeys. Psychopharmacology (Berl) (1977) 0.95
Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol (2000) 0.95
Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl (1999) 0.95
Comparison of self-reported drug use with quantitative and qualitative urinalysis for assessment of drug use in treatment studies. NIDA Res Monogr (1997) 0.95
Second-order schedules of drug injection. Fed Proc (1975) 0.95
Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther (1999) 0.95
Nalorphine-induced changes in morphine self-administration in rhesus monkeys. J Pharmacol Exp Ther (1971) 0.94
Bovine leukosis. I. Seasonal influences on lymphocytosis. Can J Comp Med (1974) 0.94